Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes

Learn about integrating CAR T-cell therapy into the management of your patients with DLBCL, FL, MCL, and CLL/SLL to improve outcomes with an on-demand webcast, downloadable slideset, and expert commentary.

Share

Program Content

Activities

Integrating CAR-T Therapy in Lymphoma
Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2023

Activities

CAR T Therapy in Lymphomas
Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2023

Expires: June 22, 2024

Activities

FAQs: CAR T-Cell Tx in Lymphomas
Experts Answer Questions on Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 27, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb